+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

COVID-19 Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2026
  • Region: Global
  • Fairfield Market Research
  • ID: 6232976
Description Jump to:
The COVID-19 Diagnostics Market is poised for steady growth, with a market valuation of USD 4.6 billion in 2026, expected to reach USD 6.69 billion by 2033, registering a CAGR of 5.5% during the forecast period. The ongoing demand for rapid and accurate COVID-19 testing, coupled with advancements in diagnostic technologies, continues to shape the global landscape for COVID-19 diagnostics.

Market Insights

The COVID-19 diagnostics market has emerged as a critical component of global healthcare infrastructure. Increased awareness regarding the importance of early detection and timely intervention has bolstered demand for diagnostic solutions. Governments and healthcare organizations worldwide are investing in testing infrastructure to control outbreaks and monitor disease spread effectively.

PCR-based testing remains a cornerstone of COVID-19 diagnostics due to its high sensitivity and specificity. Alongside PCR, rapid testing methods, including lateral flow immunoassays (LFIA) and enzyme-linked immunosorbent assays (ELISA), are witnessing widespread adoption, particularly in point-of-care and home-testing settings. The integration of innovative diagnostic tools with digital platforms has further enhanced test accessibility and reporting efficiency.

Drivers

Several factors are propelling growth in the COVID-19 diagnostics market:

  • Rising Need for Early Detection: Timely diagnosis is essential for containing infections and mitigating community transmission.
  • Technological Advancements: Development of high-throughput PCR systems, rapid antigen tests, and multiplex assays has improved testing efficiency and accuracy.
  • Government Initiatives: Regulatory support, funding, and widespread testing campaigns are enabling the deployment of diagnostic solutions in multiple settings.
  • Increasing Home Testing Adoption: Home-based diagnostic kits are gaining popularity, offering convenience and reducing pressure on healthcare facilities.

Business Opportunities

The market presents significant opportunities for diagnostics manufacturers and service providers. Growing adoption of point-of-care testing and home-based diagnostics offers avenues for innovative product development. Companies can leverage partnerships and collaborations to expand geographic reach, improve supply chain efficiency, and develop next-generation diagnostic solutions that cater to both urban and rural populations. Additionally, integrating AI and IoT in testing devices can enhance predictive capabilities and real-time monitoring.

Region Analysis

North America dominates the COVID-19 diagnostics market, driven by well-established healthcare infrastructure, high testing rates, and substantial investments in diagnostic technology. Europe follows closely, with a focus on mass testing, regulatory support, and public health initiatives. The Asia-Pacific region is expected to witness the fastest growth, fueled by rising testing awareness, increasing healthcare expenditure, and expanding diagnostic facilities in countries such as India, China, and Japan. Latin America and Middle East & Africa are experiencing gradual market growth due to expanding healthcare access and ongoing efforts to strengthen testing networks.

Key Players

Leading companies operating in the global COVID-19 diagnostics market include:

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • Siemens Healthineers AG
  • Danaher Corporation (including Beckman Coulter)
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company (BD)
  • PerkinElmer, Inc.
  • Hologic, Inc.
  • Cepheid (Danaher Group)
  • Mesa Biotech (now part of Thermo Fisher)
  • Abbott Rapid Diagnostics (Alere)
  • Seegene, Inc.
  • Meridian Bioscience, Inc.

Segmentation

By Product

  • Instruments
  • Reagents & Kits

By Technology

  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Lateral Flow Immunoassay (LFIA)
  • Others

By Sample Type

  • Oropharyngeal & Nasopharyngeal Swabs
  • Nasal Swabs
  • Blood

By Setting

  • Lab-based
  • Point of Care

By End-user

  • Hospitals & Clinics
  • Laboratories & Diagnostic Centers
  • Home Testing
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global COVID-19 Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global COVID-19 Diagnostics Market Outlook, 2020-2033
3.1. Global COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
3.1.1. Instruments
3.1.2. Reagents & Kits
3.2. Global COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
3.2.1. Polymerase Chain Reaction (PCR)
3.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
3.2.3. Lateral Flow Immunoassay (LFIA)
3.2.4. Others
3.3. Global COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
3.3.1. Oropharyngeal & Nasopharyngeal Swabs
3.3.2. Nasal Swabs
3.3.3. Blood
3.4. Global COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
3.4.1. Lab-based
3.4.2. Point of Care
3.5. Global COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
3.5.1. Hospitals & Clinics
3.5.2. Laboratories & Diagnostic Centers
3.5.3. Home Testing
3.5.4. Others
3.6. Global COVID-19 Diagnostics Market Outlook, by Region, Value (US$ Mn), 2020-2033
3.6.1. North America
3.6.2. Europe
3.6.3. Asia-Pacific
3.6.4. Latin America
3.6.5. Middle East & Africa
4. North America COVID-19 Diagnostics Market Outlook, 2020-2033
4.1. North America COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
4.1.1. Instruments
4.1.2. Reagents & Kits
4.2. North America COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
4.2.1. Polymerase Chain Reaction (PCR)
4.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
4.2.3. Lateral Flow Immunoassay (LFIA)
4.2.4. Others
4.3. North America COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
4.3.1. Oropharyngeal & Nasopharyngeal Swabs
4.3.2. Nasal Swabs
4.3.3. Blood
4.4. North America COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
4.4.1. Lab-based
4.4.2. Point of Care
4.5. North America COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
4.5.1. Hospitals & Clinics
4.5.2. Laboratories & Diagnostic Centers
4.5.3. Home Testing
4.5.4. Others
4.6. North America COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
4.6.1. U.S. COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
4.6.2. U.S. COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
4.6.3. U.S. COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
4.6.4. U.S. COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
4.6.5. U.S. COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
4.6.6. Canada COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
4.6.7. Canada COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
4.6.8. Canada COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
4.6.9. Canada COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
4.6.10. Canada COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
4.7. BPS Analysis/Market Attractiveness Analysis
5. Europe COVID-19 Diagnostics Market Outlook, 2020-2033
5.1. Europe COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
5.1.1. Instruments
5.1.2. Reagents & Kits
5.2. Europe COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
5.2.1. Polymerase Chain Reaction (PCR)
5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3. Lateral Flow Immunoassay (LFIA)
5.2.4. Others
5.3. Europe COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Nasal Swabs
5.3.3. Blood
5.4. Europe COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
5.4.1. Lab-based
5.4.2. Point of Care
5.5. Europe COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
5.5.1. Hospitals & Clinics
5.5.2. Laboratories & Diagnostic Centers
5.5.3. Home Testing
5.5.4. Others
5.6. Europe COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
5.6.1. Germany COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.2. Germany COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.3. Germany COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.4. Germany COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.5. Germany COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.6. Italy COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.7. Italy COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.8. Italy COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.9. Italy COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.10. Italy COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.11. France COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.12. France COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.13. France COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.14. France COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.15. France COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.16. U.K. COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.17. U.K. COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.18. U.K. COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.19. U.K. COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.20. U.K. COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.21. Spain COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.22. Spain COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.23. Spain COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.24. Spain COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.25. Spain COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.26. Russia COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.27. Russia COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.28. Russia COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.29. Russia COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.30. Russia COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.31. Rest of Europe COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.32. Rest of Europe COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.33. Rest of Europe COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.34. Rest of Europe COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.35. Rest of Europe COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.7. BPS Analysis/Market Attractiveness Analysis
6. Asia-Pacific COVID-19 Diagnostics Market Outlook, 2020-2033
6.1. Asia-Pacific COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
6.1.1. Instruments
6.1.2. Reagents & Kits
6.2. Asia-Pacific COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.3. Lateral Flow Immunoassay (LFIA)
6.2.4. Others
6.3. Asia-Pacific COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
6.3.1. Oropharyngeal & Nasopharyngeal Swabs
6.3.2. Nasal Swabs
6.3.3. Blood
6.4. Asia-Pacific COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
6.4.1. Lab-based
6.4.2. Point of Care
6.5. Asia-Pacific COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
6.5.1. Hospitals & Clinics
6.5.2. Laboratories & Diagnostic Centers
6.5.3. Home Testing
6.5.4. Others
6.6. Asia-Pacific COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
6.6.1. China COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.2. China COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.3. China COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.4. China COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.5. China COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.6. Japan COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.7. Japan COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.8. Japan COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.9. Japan COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.10. Japan COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.11. South Korea COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.12. South Korea COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.13. South Korea COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.14. South Korea COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.15. South Korea COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.16. India COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.17. India COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.18. India COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.19. India COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.20. India COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.21. Southeast Asia COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.22. Southeast Asia COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.23. Southeast Asia COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.24. Southeast Asia COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.25. Southeast Asia COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.26. Rest of SAO COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.27. Rest of SAO COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.28. Rest of SAO COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.29. Rest of SAO COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.30. Rest of SAO COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.7. BPS Analysis/Market Attractiveness Analysis
7. Latin America COVID-19 Diagnostics Market Outlook, 2020-2033
7.1. Latin America COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
7.1.1. Instruments
7.1.2. Reagents & Kits
7.2. Latin America COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
7.2.1. Polymerase Chain Reaction (PCR)
7.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.3. Lateral Flow Immunoassay (LFIA)
7.2.4. Others
7.3. Latin America COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
7.3.1. Oropharyngeal & Nasopharyngeal Swabs
7.3.2. Nasal Swabs
7.3.3. Blood
7.4. Latin America COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
7.4.1. Lab-based
7.4.2. Point of Care
7.5. Latin America COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
7.5.1. Hospitals & Clinics
7.5.2. Laboratories & Diagnostic Centers
7.5.3. Home Testing
7.5.4. Others
7.6. Latin America COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
7.6.1. Brazil COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.2. Brazil COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.3. Brazil COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.4. Brazil COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.5. Brazil COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.6. Mexico COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.7. Mexico COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.8. Mexico COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.9. Mexico COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.10. Mexico COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.11. Argentina COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.12. Argentina COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.13. Argentina COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.14. Argentina COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.15. Argentina COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.16. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.17. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.18. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.19. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.20. Rest of LATAM COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.7. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa COVID-19 Diagnostics Market Outlook, 2020-2033
8.1. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
8.1.1. Instruments
8.1.2. Reagents & Kits
8.2. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
8.2.1. Polymerase Chain Reaction (PCR)
8.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.3. Lateral Flow Immunoassay (LFIA)
8.2.4. Others
8.3. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
8.3.1. Oropharyngeal & Nasopharyngeal Swabs
8.3.2. Nasal Swabs
8.3.3. Blood
8.4. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
8.4.1. Lab-based
8.4.2. Point of Care
8.5. Middle East & Africa COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
8.5.1. Hospitals & Clinics
8.5.2. Laboratories & Diagnostic Centers
8.5.3. Home Testing
8.5.4. Others
8.6. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
8.6.1. GCC COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.2. GCC COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.3. GCC COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.4. GCC COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.5. GCC COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.6. South Africa COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.7. South Africa COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.8. South Africa COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.9. South Africa COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.10. South Africa COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.11. Egypt COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.12. Egypt COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.13. Egypt COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.14. Egypt COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.15. Egypt COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.16. Nigeria COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.17. Nigeria COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.18. Nigeria COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.19. Nigeria COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.20. Nigeria COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.21. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.22. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.23. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.24. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.25. Rest of Middle East COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.7. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Thermo Fisher Scientific Inc.
9.4.3. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
9.4.4. Siemens Healthineers AG
9.4.5. Danaher Corporation (including Beckman Coulter)
9.4.6. Bio-Rad Laboratories, Inc.
9.4.7. QuidelOrtho Corporation
9.4.8. Becton, Dickinson and Company (BD)
9.4.9. PerkinElmer, Inc.
9.4.10. Hologic, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • Siemens Healthineers AG
  • Danaher Corporation (including Beckman Coulter)
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company (BD)
  • PerkinElmer, Inc.
  • Hologic, Inc.
  • Cepheid (Danaher Group)
  • Mesa Biotech (now part of Thermo Fisher)
  • Abbott Rapid Diagnostics (Alere)
  • Seegene, Inc.
  • Meridian Bioscience, Inc.

Related Topics

Related Reports

COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type, Mode, End Use, and Region 2025-2033 - Product Image

COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type, Mode, End Use, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033 - Product Image

Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033

  • Report
  • 227 Pages
  • Global
From
U.S. HSV Testing Market Size, Share & Trends Analysis by Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), by Test Type, by Sample Type (Blood, Swabs, Cerebrospinal Fluid), by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

U.S. HSV Testing Market Size, Share & Trends Analysis by Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), by Test Type, by Sample Type (Blood, Swabs, Cerebrospinal Fluid), by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • United States
From
Uterine Cancer Diagnostic Testing Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Uterine Cancer Diagnostic Testing Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 193 Pages
  • Global
From
Europe Colorectal Cancer Screening and Diagnostic Market: Analysis and Forecast, 2023-2033 - Product Image

Europe Colorectal Cancer Screening and Diagnostic Market: Analysis and Forecast, 2023-2033

  • Report
  • 75 Pages
  • Europe
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.